Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Diphtheria Market From 2025 To 2029?
In recent years, the market size of diphtheria has experienced a robust growth. It is expected to rise from $8.91 billion in 2024 to $9.39 billion in 2025 with a compound annual growth rate (CAGR) of 5.4%. Factors such as vaccine development, immunization drives, heightened awareness and enhanced healthcare infrastructure are the catalysts for the growth witnessed in the previous period.
The diphtheria market is projected to experience significant expansion in the coming years. It is estimated to reach $12.1 billion by 2029, with a compound annual growth rate (CAGR) of 6.5%. The projected growth during the forecast period is due to factors such as emerging outbreaks, booster vaccination programs, worldwide travel and migration, and readiness in public health. The forecast period will also witness key trends like combination vaccines, telemedicine for vaccination, initiatives for vaccine equality, and collaborations between public and private sectors.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13016&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theDiphtheria Market?
The increasing occurrence of bacterial infections is anticipated to boost the diphtheria market’s progression in the future. Bacterial infections can be defined as diseases or conditions caused by bacterial proliferation or the toxins they introduce into the body. Diphtheria is a severe infection triggered by bacterial strains that inhibit the immune system and enhance the growth of Corynebacterium diphtheriae. For example, GOV.UK, a government website based in the UK, reported in September 2024 that during the fiscal year 2022 to 2023, NHS acute trusts in England noted a total of 38,757 E. coli bacteremia cases, with 7,881 cases, or 20.3%, designated as originating from hospitals. Hence, the escalating occurrence of bacterial infections is expected to fuel the diphtheria market.
Which Segments in the Diphtheria Offer the Most Growth?
The diphtheriamarket covered in this report is segmented –
1) By Type: Diphtheria; Skin Diphtheria; Other Types
2) By Diagnosis: Physical Examination; Throat Culture; Other Diagnosis
3) By Treatment: Antibiotics; Antitoxin; Other Treatments
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
Subsegments:
1) By Diphtheria: Respiratory Diphtheria; Non-respiratory Diphtheria
2) By Skin Diphtheria: Cutaneous Diphtheria
3) By Other Types: Diphtheritic Myocarditis; Diphtheritic Neuritis
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13016&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theDiphtheria Market?# Market?
Asia-Pacific was the largest region in the diphtheria market in 2024. The regions covered in diphtheria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Current Market Growth and Trends in the Diphtheria Industry?
Leading firms in the diphtheria market are striving to remain competitive by creating novel drugs and securing regulatory approvals. For example, in October 2022, the US Food and Drug Administration (FDA) gave its approval to UK-based pharmaceutical and biotechnology corporation GlaxoSmithKline PLC for their BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, adsorbed; Tdap) to be used for immunization during the third pregnancy trimester. This is intended to guard against pertussis, or whooping cough, in children below two months old. This Tdap immunization, when given during pregnancy, offers optimal protection against whooping cough in the initial months of a newborn’s life, as protective antibodies are passed from the mother to the infant.
View the full report here:
https://www.thebusinessresearchcompany.com/report/diphtheria-global-market-report
What Are the Key Elements That Define the Diphtheria Market?
Diphtheria is a bacterial illness caused by strains of bacteria called bacteria Corynebacterium diphtheriae which make a toxin that predominantly affects the mucous membranes of the throat and nose and can also affect other regions of the body in severe instances. It can be identified by throat discomfort, weakness, fever, swollen neck glands, breathing difficulties due to tissues clogging the nose and throat and difficulty in swallowing.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13016
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model